CGTx Archives - Page 2 of 4 - Precision Medicine Group

Conference: 4th Annual Gene Therapy Immunogenicity Summit

Morgan Labbree2023-08-24T13:33:14-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s 4th Annual Gene Therapy Immunogenicity Summit, September 5 – 7, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Schedule a meeting with one our our experts
Stop by Precision’s booth
Be sure to attend Precision’s own, Travis Harrison’s presentation on September 6th, 2023, at 9:30 AM EDT

You can register for the 4th Annual Gene Therapy Immunogenicity Summit below:

REGISTER HERE

(more…)

On Demand: The Future of Cell Therapy Development and Delivery

Morgan Labbree2023-08-24T13:19:48-04:00Cell & Gene Therapy, Events|

Sponsored by Precision ADVANCE, this Endpoints webinar convened leading advanced therapy experts to discuss the future of cell therapy development and delivery. This discussion was moderated by John Khoury: EVP (Project Farma), and included insights from Chris McDonald: Global Head of Tech Ops (Kite Pharma), Mark Frattini: CMO (Cellectis), Jason Foster: CEO & ED (Ori Biotech), and Phil Cyr: SVP (Precision Value & Health).

(more…)

Conference: CAR-TCR Summit, 2023

Morgan Labbree2023-07-31T15:37:47-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s CAR-TCR Summit August 29 – September 1, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization of cell therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below.

Precision ADVANCE will hold a welcome reception on August 29, 2023, at 5:30 pm.
Project Farma will be facilitating a Manufacturing track panel discussion “Keys to Success for a Commercial – Ready Cell Therapy Facility” on August 30, 2023, 4:30 – 5:00 pm.
Precision ADVANCE will be facilitating an Early-Stage Clinical Strategy track panel discussion “Strategies for Successful Clinical Development of Cell Therapies” on August 30, 2023, 4:30 – 5:00 pm.
Precision ADVANCE will have a plenary speaking position “The Journey of Commercializing Cell Therapies” on August 31, 2023, 8:05 – 8:50 am.

Connect with our Advanced Therapy experts

Visit us at booth 90 in the exhibition area
Schedule in-person or virtual meetings with one of our experts
Attend our ADVANCE-sponsored Welcome Reception on August 29, 2023, at 5:30 PM ET

(more…)

Webinar: Driving Successful Therapeutic and Diagnostic Development: Effective Practices for Integrating Biomarkers, Biospecimens, and Science from Concept through Clinic to Cloud

Lisa Lewin2023-07-07T10:42:48-04:00Events|

In the rapidly evolving world of precision medicine, the successful integration of high-quality biospecimens and well-defined biomarkers is a fundamental aspect. Together with robust scientific methodologies and validation procedures, they drive discovery, clinical development, and the advent of Artificial Intelligence (AI)-driven diagnostics.

This webinar delves into the practical application of biospecimens in critical areas like neurodegeneration, immuno-oncology, and oncology. It outlines the development of assays for clinical application, the creation of multiplexed Immunohistochemistry (IHC) assays, and the use of sequenced biospecimens in the development and diagnosis of targeted therapies.

Key topics will also highlight the value of Tissue Microarrays (TMAs), the advantage of accessing diverse disease indications, the necessity for substantial tissue cohorts for clinical trial assay validation, and the role of tissue images (Hematoxylin & Eosin (H&E), IHC) and related sample data (Next-Generation Sequencing (NGS)) in shaping AI-based diagnostics.

(more…)

Webinar: Maximizing Efficiency in Your Next State of the Art Facility Build

Morgan Labbree2023-06-20T11:58:00-04:00Cell & Gene Therapy, Events|

Sponsored by Project Farma, a Precision for Medicine Company, this panel will feature insights from industry leaders on their organization’s risk-based approaches, strategies, and regulatory, manufacturing, and commercial needs to maximize efficiency in their facility build.

This discussion will be moderated by Chad Salisbury: SVP (Project Farma), and include insights from Adam Barlow: CEO and Founder (Baseline Controls), Antinea Chair: VP, Technical Operations (Cellares), Steve Marr: Head of Capital, Real Estate, and Facilities (Spark), Matthew Smith: Head of Project Delivery (Novartis), and Sarah Stoll: Sr. Director (Project Farma).

(more…)

White Paper: Moving CGTx Clinical Development Forward in 2023

Morgan Labbree2023-06-20T14:21:24-04:00Cell & Gene Therapy, Thought Leadership|

Clinical trials are foundational to developing innovative, life-saving treatments and cures for patients. For developers of cell and gene therapy (CGTx) products, the path to clinical success is fraught with vast and complex challenges. The CGTx field is becoming more crowded, with increased clinical trial volume and an influx of less-experienced sponsors contributing to an increase in clinical holds in the category. Such challenges intensify the pressure to succeed in a fiercely competitive environment.

(more…)

White Paper: Market Trends and Expectations for Advanced Therapies in 2023

Morgan Labbree2023-07-06T11:12:25-04:00Cell & Gene Therapy, Thought Leadership|

The cell and gene therapy space has undergone transformational change in the last few years, driven by the promise these modalities have demonstrated in addressing rare and intractable diseases. Achievements in the CAR-T therapy space – there are now six approved CAR-T treatments on the market – in conjunction with breakthroughs in gene therapy and viral vector drugs, have signaled a new era of innovation aimed at furthering cell and gene therapies within the greater healthcare landscape.

(more…)

Conference: 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit

Morgan Labbree2023-06-15T15:58:07-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, June 20-21, 2023, in Vienna, Austria. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Schedule a meeting with one our our experts
Be sure to attend Precision’s own, Houria Bachtarzi’s presentation on June 20, 2023, at 10:10 AM CEST

You can register for the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit below:

REGISTER HERE

(more…)

On-Demand: Cell & Gene Day, 2023

Lisa Lewin2023-07-10T12:09:50-04:00Cell & Gene Therapy, Events|

Even as cell and gene therapies inspire hope for patients who previously had none, the path to commercialization is littered with roadblocks. There is a pressing need for increased efficiency, enhanced safety, and innovative approach to pricing and access. How are leading CGTx innovators approaching these challenges? Find out at Cell & Gene Day 2023, a free virtual event, streaming on demand HERE.

(more…)

Event: Cell & Gene Reception @ BIO, 2023

Morgan Labbree2023-05-23T13:40:58-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision is honored to be a co-host of this year’s ARM Cell & Gene Reception @ BIO, May 5, 2023, in Boston, MA. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!

Connect with our Advanced Therapy experts!